Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage

Practical Neurology

Volumn 9, Issue 4, 2009, Pages 195-209

  Rinkel, Gabriel J E ^a   Klijn, Catharine J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

BRAIN ISCHEMIA; FEVER; HUMAN; HYDROCEPHALUS; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVIEW; STANDARD; SUBARACHNOID HEMORRHAGE;

BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CRITICAL CARE; FEVER; HUMANS; HYDROCEPHALUS; INTENSIVE CARE UNITS; RECURRENCE; SUBARACHNOID HEMORRHAGE;

EID: 70349787133     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/jnnp.2009.182444     Document Type: Review

References (79)

1. Hop JW, Rinkel GJE, Algra A, et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660-4.
2. Macrea LM, Tramer MR, Walder B. Spontaneous subarachnoid hemorrhage and serious cardiopulmonary dysfunction-a systematic review. Resuscitation 2005;65:139-48.
3. Schuiling WJ, de Weerd AW, Dennesen PJ, et al. The simplified acute physiology score to predict outcome in patients with subarachnoid hemorrhage. Neurosurgery 2005;57:230-6.
4. Sarker SJ, Heuschmann PU, Burger I, et al. Predictors of survival after haemorrhagic stroke in a multi-ethnic population: The South London Stroke Register (SLSR). J Neurol Neurosurg Psychiatry 2008;79:260-5.
5. Frontera JA, Fernandez A, Schmidt JM, et al. Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery 2008;62:80-7.
6. Wijdicks EFM, Vermeulen M, Murray GD, et al. The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 1990;92:111-17.
7. Hasan D, Vermeulen M, Wijdicks EFM, et al. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke 1989;20:1511-15.
8. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care 2003;7:374-84.
9. Wijdicks EFM, Vermeulen M, Hijdra A, et al. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 1985;17:137-40.
10. Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage. Relationship to vasospasm and outcome. Neurology 2001;56:1299-304.
11. Siironen J, Juvela S, Varis J, et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, doubleblind, placebo-controlled clinical trial. J Neurosurg 2003;99:953-9.
12. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000;CD001484.
13. Black PM, Crowell RM, Abbott WM. External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms. Neurosurgery 1986;18:25-8.
14. Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005;65:865-9.
15. Lin CL, Dumont AS, Lieu AS, et al. Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:978-85.
16. Claassen J, Bateman BT, Willey JZ, et al. Generalized convulsive status epilepticus after nontraumatic subarachnoid hemorrhage: the nationwide inpatient sample. Neurosurgery 2007;61:60-5.
17. Dennis LJ, Claassen J, Hirsch LJ, et al. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurg 2002;51:1136-44.
18. Claassen J, Hirsch LJ, Frontera JA, et al. Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care 2006;4:103-12.
19. Kull LL, Emerson RG. Continuous EEG monitoring in the intensive care unit: technical and staffing considerations. J Clin Neurophysiol 2005;22:107-18.
20. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809-17.
21. Foy PM, Chadwick DW, Rajgopalan N, et al. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 1992;55:753-7.
22. Feigin VL, Anderson N, Rinkel GJE, et al. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 2005;CD004583.
23. Katayama Y, Haraoka J, Hirabayashi H, et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2373-5.
24. Harrigan MR. Cerebral salt wasting syndrome. Crit Care Clin 2001;17:125-38.
25. Suarez JI, Qureshi AI, Parekh PD, et al. Administration of hypertonic (3%) sodium chloride/ acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol 1999;11:178-84.
26. Hasan D, Lindsay KW, Wijdicks EF, et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 1989;20:1156-61.
27. Mori T, Katayama Y, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1999;91:947-52.
28. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006;34:617-23.
29. Dorhout Mees SM, van Dijk GW, Algra A, et al. Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003;61:1132-3.
30. Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007;19:156-60.
31. Dorhout Mees SM, Luitse MJ, van den Bergh WM, et al. Fever after aneurysmal subarachnoid hemorrhage: relation with extent of hydrocephalus and amount of extravasated blood. Stroke 2008;39:2141-3.
32. Todd MM, Hindman BJ, Clarke WR, et al. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005;352:135-45.
33. Parr MJ, Finfer SR, Morgan MK. Reversible cardiogenic shock complicating subarachnoid haemorrhage. BMJ 1996;313:681-3.
34. Schuiling WJ, Dennesen PJ, Rinkel GJE. Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2005;3:1-10.
35. Parr MJ, Finfer SR, Morgan MK. Reversible cardiogenic shock complicating subarachnoid haemorrhage. BMJ 1996;313:681-3.
36. Deehan SC, Grant IS. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intensive Care Med 1996;22:672-6.
37. Kahn JM, Caldwell EC, Deem S, et al. Acute lung injury in patients with subarachnoid hemorrhage: Incidence, risk factors, and outcome. Crit Care Med 2006;34:196-202.
38. Muench E, Bauhuf C, Roth H, et al. Effects of positive end-expiratory pressure on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation. Crit Care Med 2005;33:2367-72.
39. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001;32:1176-80.
40. Roos YBWEM, Rinkel GJE, Vermeulen M, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2003;CD001245.
41. Hillman J, Fridriksson S, Nilsson O, et al. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 2002;97:771-8.
42. Pickard JD, Kirkpatrick PJ, Melsen T, et al. Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage. Blood Coagul Fibrinolysis 2000;11(Suppl 1):S117-20.
43. Nussbaum ES, Janjua TM, Defillo A, et al. Perioperative use of recombinant factor VII to prevent intraoperative aneurysm rupture in high risk patients: a preliminary safety evaluation. Neurocrit Care 2009;10:55-60.
44. Rabinstein AA, Weigand S, Atkinson JL, et al. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005;36:992-7.
45. Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-6.
46. Vergouwen MD, Vermeulen M, Coert BA, et al. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761-70.
47. Dorhout Mees SM, Rinkel GJE, Feigin V, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD000277.
48. Kronvall E, Undren P, Romner B, et al. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg 2009;110:58-63.
49. Dorhout Mees SM. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group. Int J Stroke 2008;3:63-5.
50. Dorhout Mees SM, van den Bergh WM, Algra A, et al. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD006184.
51. Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II-Clinical aspects and recommendations. Neurosurg 2000;46:1360-76.
52. van den Bergh WM, Kerr RS, Algra A, et al. The effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage. Stroke 2009 April 23 (Epub ahead of print).
53. Sillberg VA, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage. A meta-analysis. Stroke 2008;39:2622-6.
54. Jang YG, Ilodigwe D, Macdonald RL. Metaanalysis of tirilazad mesylate in patients with aneurismal subarachnoid hemorrhage. Neurocrit Care 2009;10:141-7.
55. Shaw MD, Vermeulen M, Murray GD, et al. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 2000;93:992-7.
56. Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 2005;103:9-17.
57. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1). Randomized, doubleblind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-21.
58. Nogueira RG, Bodock MJ, Koroshetz WJ, et al. Highdose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study. Neurocrit Care 2007;7:194-202.
59. Springborg JB, Moller C, Gideon P, et al. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial. Acta Neurochir (Wien) 2007;149:1089-101.
60. Klimo P Jr, Kestle JR, MacDonald JD, et al. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2004;100:215-24.
61. Amin-Hanjani S, Ogilvy CS, Barker FG. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004;54:326-34.
62. Hamada JI, Kai Y, Morioka M, et al. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna. A prospective randomized study. Stroke 2003;34:2549-54.
63. Amin-Hanjani S, Schwartz RB, Sathi S, et al. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery 1999;44:1113-16.
64. Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging 2006;16:170-5.
65. Hoh BL, Aghi M, Pryor JC, et al. Heparin-induced thrombocytopenia type II in subarachnoid hemorrhage patients: incidence and complications. Neurosurgery 2005;57:243-8.
66. Jestaedt L, Pham M, Bartsch AJ, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 2008;62:610-17.
67. Rabinstein AA, Friedman JA, Nichols DA, et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:1778-82.
68. Hasan D, Vermeulen M, Wijdicks EFM, et al. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke 1989;20:747-53.
69. Hasan D, Lindsay KW, Vermeulen M. Treatment of acute hydrocephalus after subarachnoid hemorrhage with lumbar puncture. Stroke 1991;22:190-4.
70. Ruijs AC, Dirven CM, Algra A, et al. The risk of rebleeding after external lumbar drainage in patients with untreated ruptured cerebral aneurysms. Acta Neurochir (Wien) 2005;147:1157-62.
71. Hellingman CA, Beijer I, van Dijk GW, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:96-9.
72. Fountas KN, Kapsalaki EZ, Machinis T, et al. Review of the literature regarding the relationship of rebleeding and external ventricular drainage in patients with subarachnoid hemorrhage of aneurysmal origin. Neurosurg Rev 2006;29:14-18.
73. Saladino A, White JB, Wijdicks EF, et al. Malplacement of ventricular catheters by neurosurgeons: a single institution experience. Neurocrit Care 2009;10:248-52.
74. Beer R, Lackner P, Pfausler B, et al. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008;255:1617-24.
75. Binz DD, Toussaint LG III, Friedman JA. Hemorrhagic complications of ventriculostomy placement: a meta-analysis. Neurocrit Care 2009;10:253-6.
76. Wong GK, Poon WS, Wai S, et al. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial. J Neurol Neurosurg Psychiatry 2002;73:759-61.
77. Choksey MS, Malik IA. Zero tolerance to shunt infections: can it be achieved? J Neurol Neurosurg Psychiatry 2004;75:87-91.
78. Korinek AM, Reina M, Boch AL, et al. Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien) 2005;147:39-45.
79. Roos YBWEM, Rinkel GJE, Vermeulen M, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2000;CD001245.